Calumet Specialty Products
CLMT
188 hedge funds and large institutions have $1.66B invested in Calumet Specialty Products in 2026 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 70 increasing their positions, 54 reducing their positions, and 28 closing their positions.
43% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 28
30% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 54
4% more funds holding
Funds holding: 180 → 188 (+8)
2% more capital invested
Capital invested by funds: $1.63B → $1.66B (+$29.6M)
0.48% more ownership
Funds ownership: 52.35% → 52.82% (+0.48%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
55% less call options, than puts
Call options by funds: $80.4M | Put options by funds: $179M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$24.6M |
| 2 |
TSC
Two Seas Capital
Rye,
New York
|
+$22.2M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$14.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$13.1M |
| 5 |
HAI
Hennessy Advisors Inc
Novato,
California
|
+$9.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAA
Adams Asset Advisors
Dallas,
Texas
|
-$40.2M |
| 2 |
WDOM
Wasserstein Debt Opportunities Management
New York
|
-$20.5M |
| 3 |
Morgan Stanley
New York
|
-$11.6M |
| 4 |
Walleye Capital
New York
|
-$10.2M |
| 5 |
JP Morgan Chase
New York
|
-$8.15M |
CLMT Hedge Fund Activity: Q2 2026 in Review
188 of the 8,286 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q2 2026, worth a combined $1.66B — up 1.8% from $1.63B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new CLMT positions and 28 closed out — a net gain of 12 holders — while 70 added to existing stakes and 54 trimmed.
The largest buyer was Barclays, adding an estimated $24.6M. The largest seller was Adams Asset Advisors, cutting an estimated $40.2M.
- 188 institutional investors held Calumet Specialty Products (CLMT) as of Q2 2026, up from 180 in Q1 2026.
- Funds reported $1.66B of Calumet Specialty Products stock for Q2 2026, up 1.8% quarter-over-quarter.
- 40 funds opened new Calumet Specialty Products positions in Q2 2026 and 28 closed out, a net change of +12 holders.
- The largest Calumet Specialty Products buyer in Q2 2026 was Barclays, an estimated $24.6M added.
- The largest Calumet Specialty Products seller in Q2 2026 was Adams Asset Advisors, an estimated $40.2M sold.
Based on aggregated 13F filings for Q2 2026.